US Patent Issued to MIGAL GALILEE RESEARCH INSTITUTE on Oct. 7 for "5,6-diHETE lactone for treatment of microvascular dysfunction" (Israeli Inventor)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,864, issued on Oct. 7, was assigned to MIGAL GALILEE RESEARCH INSTITUTE LTD. (Kiryat Shmona, Israel).

"5,6-diHETE lactone for treatment of microvascular dysfunction" was invented by Andrea Szuchman-Sapir (Upper Galilee, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides 5,6 dihydroxyeicosatetraenoic acid (5,6-diHETE) lactone or a pharmaceutical composition comprising 5,6-diHETE lactone and a pharmaceutically acceptable carrier, and uses thereof for inducing vasodilation, for treating a disease, disorder or condition associated with microvascular dysfunction, or for preventing, or reducing the risk of, developing a ca...